Director/PDMR Shareholding

IP Group PLC
04 April 2008





                                                                   04 APRIL 2008


                               DIRECTOR DEALING


IP Group plc (LSE: IPO) ('IP Group' or the 'Company' or 'Group'), the UK's
leading university intellectual property commercialisation company, was today
notified by Alan Aubrey, Chief Executive Officer, that he had transferred 93,450
ordinary shares in IP Group at a price of 106p per share into his personal
pension.

This transaction has no effect on Alan Aubrey's beneficial ownership; he
continues to hold a total direct and indirect  voting right interest in 854,865
ordinary shares in IP Group, being approximately 0.34% of the issued ordinary
share  capital of IP Group of 250,291,965 ordinary shares of 2p each.





For further information, please contact:

IP Group                                           0845 0742929
Alan Aubrey, Chief Executive Officer
Liz Vaughan-Adams (Communications)                 020 7444 0062/07979853802




Notes for Editors

About IP Group

IP Group is an intellectual property (IP) commercialisation company that
specialises in commercialising university technology. Founded in 2001, IP Group
listed on AIM in October 2003 and moved to the Official List in June 2006. It
has made two acquisitions to date - Techtran, a company set up to commercialise
university intellectual property under a long term contract with the University
of Leeds, in 2005 and Top Technology Ventures, an investment adviser to early
stage technology venture capital funds, in 2004.

IP Group has formed long-term partnerships with ten universities - the
University of Oxford, King's College London, CNAP/University of York, the
University of Leeds, the University of Bristol, the University of Surrey, the
University of Southampton, Queen Mary (University of London), the University of
Bath and the University of Glasgow.

The Company's portfolio is diverse with exposure to five main sectors - Energy &
Renewables, Healthcare & Life Sciences: Non-therapeutics, Healthcare & Life
Sciences: Therapeutics, IT & Communications and Chemicals & Materials. To date,
ten portfolio companies have listed on the AIM market of the London Stock
Exchange, one on PLUS Markets and there have been two trade sales. IP Group also
established three 'Modern-themed' subsidiaries - Modern Biosciences, Modern
Water and Modern Waste. Modern Water was the first of these subsidiaries to
float on AIM in June 2007.


For more information, please visit our website at www.ipgroupplc.com.


ENDS



                      This information is provided by RNS
            The company news service from the London Stock Exchange